1. Home
  2. RHLD vs FDMT Comparison

RHLD vs FDMT Comparison

Compare RHLD & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RHLD
  • FDMT
  • Stock Information
  • Founded
  • RHLD 2024
  • FDMT 2013
  • Country
  • RHLD United States
  • FDMT United States
  • Employees
  • RHLD N/A
  • FDMT N/A
  • Industry
  • RHLD
  • FDMT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RHLD
  • FDMT Health Care
  • Exchange
  • RHLD NYSE
  • FDMT Nasdaq
  • Market Cap
  • RHLD 217.1M
  • FDMT 192.2M
  • IPO Year
  • RHLD N/A
  • FDMT 2020
  • Fundamental
  • Price
  • RHLD $37.22
  • FDMT $4.32
  • Analyst Decision
  • RHLD
  • FDMT Buy
  • Analyst Count
  • RHLD 0
  • FDMT 10
  • Target Price
  • RHLD N/A
  • FDMT $32.33
  • AVG Volume (30 Days)
  • RHLD 100.9K
  • FDMT 436.5K
  • Earning Date
  • RHLD 08-15-2025
  • FDMT 08-07-2025
  • Dividend Yield
  • RHLD N/A
  • FDMT N/A
  • EPS Growth
  • RHLD N/A
  • FDMT N/A
  • EPS
  • RHLD 12.54
  • FDMT N/A
  • Revenue
  • RHLD $420,450,000.00
  • FDMT $23,000.00
  • Revenue This Year
  • RHLD N/A
  • FDMT $13,048.65
  • Revenue Next Year
  • RHLD N/A
  • FDMT N/A
  • P/E Ratio
  • RHLD $3.18
  • FDMT N/A
  • Revenue Growth
  • RHLD 11.09
  • FDMT N/A
  • 52 Week Low
  • RHLD $24.22
  • FDMT $2.24
  • 52 Week High
  • RHLD $54.05
  • FDMT $28.93
  • Technical
  • Relative Strength Index (RSI)
  • RHLD N/A
  • FDMT 57.43
  • Support Level
  • RHLD N/A
  • FDMT $3.86
  • Resistance Level
  • RHLD N/A
  • FDMT $4.48
  • Average True Range (ATR)
  • RHLD 0.00
  • FDMT 0.28
  • MACD
  • RHLD 0.00
  • FDMT 0.01
  • Stochastic Oscillator
  • RHLD 0.00
  • FDMT 89.81

About RHLD RESOLUTE HOLDINGS MANAGEMENT INC

Resolute Holdings Management Inc is provide operating management services. The company has two operating segments and two reportable segments: Payment Card and Arculus. Payment Card generates its revenue through the production and sale of metal payment cards while Arculus generates its revenue through the production and sale of metal payment or nonpayment cards containing Arculus technology for authentication and/or digital asset cold storage and related services. The company generates maximum revenue Domestically.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Share on Social Networks: